Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ · Healthcare
Oramed Pharmaceuticals Inc. Long Term Debt 2016–2025
Oramed Pharmaceuticals Inc. annual long term debt history from 2018 to 2022. Long term debt refers to financial obligations that are due more than one year in the future.
- Oramed Pharmaceuticals Inc. long term debt as of December 31, 2022: 25,000.
- Oramed Pharmaceuticals Inc. long term debt for 2022 were 25,000, a 99.80% decrease from 2021.
- Oramed Pharmaceuticals Inc. long term debt for 2021 were 12.5M, a 29.87% increase from 2019.
- Oramed Pharmaceuticals Inc. long term debt for 2019 were 9.7M, a 15.19% decrease from 2018.
- Oramed Pharmaceuticals Inc. long term debt for 2018 were 11.4M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Oramed Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2022 | $0 |
| 2021 | $13 |
| 2019 | $10 |
| 2018 | $11 |
Oramed Pharmaceuticals Inc. Long Term Debt — FAQ
Oramed Pharmaceuticals Inc. (ORMP) long term debt over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ORMP's long term debt history?
The chart and table above show Oramed Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.